Neuropsin promotes oligodendrocyte death, demyelination and axonal degeneration after spinal cord injury

Neuroscience

Volumn 148, Issue 1, 2007, Pages 175-187

  Terayama, R ^a,b   Bando, Y ^a   Murakami, K ^a   Kato, K ^a   Kishibe, M ^a   Yoshida, S ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

behavior; immunofluorescence labeling; in situ hybridization; secondary injury; serine protease; tract tracing

Indexed keywords

MESSENGER RNA; NEUROPSIN; SERINE PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CRUSH TRAUMA; DEMYELINATION; GENE EXPRESSION; HINDLIMB; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; MOUSE STRAIN; NERVE CELL NECROSIS; NERVE FIBER; NERVE FIBER DEGENERATION; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL TRACT; SPINAL CORD INJURY; SURVIVAL; WHITE MATTER; WILD TYPE;

ANIMALS; BRAIN MAPPING; CELL DEATH; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HEMIPLEGIA; IN SITU HYBRIDIZATION; KALLIKREINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE FIBERS, MYELINATED; NERVE REGENERATION; NEURAL PATHWAYS; OLIGODENDROGLIA; RECOVERY OF FUNCTION; RNA, MESSENGER; SPINAL CORD; SPINAL CORD INJURIES; WALLERIAN DEGENERATION;

EID: 34547683904     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.05.037     Document Type: Article

References (62)

1. Abe Y., Nakamura H., Nakamura H., Yoshino O., Yoshino O., Oya T., Oya T., Kimura T., and Kimura T. Decreased neural damage after spinal cord injury in tPA-deficient mice. J Neurotrauma 20 (2003) 43-57
2. Agrawal S.K., and Fehlings M.G. Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J Neurosci 17 (1997) 1055-1063
3. Banik N.L., Hogan E.L., Powers J.M., and Whetstine L.J. Degradation of cytoskeletal proteins in experimental spinal cord injury. Neurochem Res 7 (1982) 1465-1475
4. Barres B.A., Jacobson M.D., Schmid R., Sendtner M., and Raff M.C. Does oligodendrocyte survival depend on axons?. Curr Biol 3 (1993) 489-497
5. Basso D.M., Beattie M.S., and Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12 (1995) 1-21
6. Berlet H.H., Ilzenhofer H., and Schulz G. Cleavage of myelin basic protein by neutral protease activity of human white matter and myelin. J Neurochem 43 (1984) 627-633
7. Blight A.R. Miracles and molecules: progress in spinal cord repair. Nat Neurosci 5 (2002) 1051-1054
8. Borgono C.A., and Diamandis E.P. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 4 (2004) 876-890
9. Borgono C.A., Michael I.P., and Diamandis E.P. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2 (2004) 257-280
10. Chantry A., Gregson N.A., and Glynn P. A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization. J Biol Chem 264 (1989) 21603-21607
11. Chen Z.L., and Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91 (1997) 917-925
12. Chen Z.L., Momota Y., Kato K., Taniguchi M., Inoue N., Shiosaka S., and Yoshida S. Expression of neuropsin mRNA in the mouse embryo and the pregnant uterus. J Histochem Cytochem 46 (1998) 313-320
13. Chen Z.L., Yoshida S., Kato K., Momota Y., Suzuki J., Tanaka T., Ito J., Nishino H., Aimoto S., Kiyama H., et al. Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J Neurosci 15 (1995) 5088-5097
14. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., and Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3 (1997) 73-76
15. Diamandis E.P., Yousef G.M., and Olsson A.Y. An update on human and mouse glandular kallikreins. Clin Biochem 37 (2004) 258-260
16. Dong H., Fazzaro A., Xiang C., Korsmeyer S.J., Jacquin M.F., and McDonald J.W. Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration. J Neurosci 23 (2003) 8682-8691
17. Faden A.I., and Simon R.P. A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann Neurol 23 (1988) 623-626
18. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., and Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24 (2004) 2143-2155
19. Fruttiger M., Montag D., Schachner M., and Martini R. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur J Neurosci 7 (1995) 511-515
20. He X.P., Shiosaka S., and Yoshida S. Expression of neuropsin in oligodendrocytes after injury to the CNS. Neurosci Res 39 (2001) 455-462
21. Hirata A., Yoshida S., Inoue N., Matsumoto-Miyai K., Ninomiya A., Taniguchi M., Matsuyama T., Kato K., Iizasa H., Kataoka Y., Yoshida N., and Shiosaka S. Abnormalities of synapses and neurons in the hippocampus of neuropsin-deficient mice. Mol Cell Neurosci 17 (2001) 600-610
22. Inman D., Guth L., and Steward O. Genetic influences on secondary degeneration and wound healing following spinal cord injury in various strains of mice. J Comp Neurol 451 (2002) 225-235
23. Kirihara T., Matsumoto-Miyai K., Nakamura Y., Sadayama T., Yoshida S., and Shiosaka S. Prolonged recovery of ultraviolet B-irradiated skin in neuropsin (KLK8)-deficient mice. Br J Dermatol 149 (2003) 700-706
24. Krystosek A., and Seeds N.W. Plasminogen activator release at the neuronal growth cone. Science 213 (1981) 1532-1534
25. Lu J., Ashwell K.W., and Waite P. Advances in secondary spinal cord injury: role of apoptosis. Spine 25 (2000) 1859-1866
26. Matsumoto-Miyai K., Ninomiya A., Yamasaki H., Tamura H., Nakamura Y., and Shiosaka S. NMDA-dependent proteolysis of presynaptic adhesion molecule L1 in the hippocampus by neuropsin. J Neurosci 23 (2003) 7727-7736
27. Matute C., Sanchez-Gomez M.V., Martinez-Millan L., and Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci U S A 94 (1997) 8830-8835
28. McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W., and Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4 (1998) 291-297
29. Mocchetti I., and Wrathall J.R. Neurotrophic factors in central nervous system trauma. J Neurotrauma 12 (1995) 853-870
30. Monard D. Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth. Trends Neurosci 11 (1988) 541-544
31. Noble L., Donovan F., Donovan F., Igarashi T., Igarashi T., Goussev S., Goussev S., Werb Z., and Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord. J Neurosci 22 (2002) 7526-7535
32. Oka A., Belliveau M.J., Rosenberg P.A., and Volpe J.J. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J Neurosci 13 (1993) 1441-1453
33. Okabe A., Momota Y., Yoshida S., Hirata A., Ito J., Nishino H., and Shiosaka S. Kindling induces neuropsin mRNA in the mouse brain. Brain Res 728 (1996) 116-120
34. Park E., Velumian A.A., and Fehlings M.G. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21 (2004) 754-774
35. Sanchez I., Hassinger L., Paskevich P.A., Shine H.D., and Nixon R.A. Oligodendroglia regulate the regional expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation. J Neurosci 16 (1996) 5095-5105
36. Sanes J.R. Roles of extracellular matrix in neural development. Annu Rev Physiol 45 (1983) 581-600
37. Sanes J.R. Extracellular matrix molecules that influence neural development. Annu Rev Neurosci 12 (1989) 491-516
38. Sato S., Quarles R.H., and Brady R.O. Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain. J Neurochem 39 (1982) 97-105
39. Scarisbrick I.A., Blaber S.I., Lucchinetti C.F., Genain C.P., Blaber M., and Rodriguez M. Activity of a newly identified serine protease in CNS demyelination. Brain 125 (2002) 1283-1296
40. Schumacher P.A., Eubanks J.H., and Fehlings M.G. Increased calpain I-mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury. Neuroscience 91 (1999) 733-744
41. Schumacher P.A., Siman R.G., and Fehlings M.G. Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J Neurochem 74 (2000) 1646-1655
42. Seeds N.W., Haffke S., Christensen K., and Schoonmaker J. Cerebellar granule cell migration involves proteolysis. Adv Exp Med Biol 265 (1990) 169-178
43. Shimizu C., Yoshida S., Shibata M., Kato K., Momota Y., Matsumoto K., Shiosaka T., Midorikawa R., Kamachi T., Kawabe A., and Shiosaka S. Characterization of recombinant and brain neuropsin, a plasticity-related serine protease. J Biol Chem 273 (1998) 11189-11196
44. Shimizu-Okabe C., Yousef G.M., Diamandis E.P., Yoshida S., Shiosaka S., and Fahnestock M. Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport 12 (2001) 2747-2751
45. Shiosaka S., and Yoshida S. Synaptic microenvironments-structural plasticity, adhesion molecules, proteases and their inhibitors. Neurosci Res 37 (2000) 85-89
46. Terayama R., Bando Y., Takahashi T., and Yoshida S. Differential expression of neuropsin and protease M/neurosin in oligodendrocytes after injury to the spinal cord. Glia 48 (2004) 91-101
47. Terayama R., Bando Y., Yamada M., and Yoshida S. Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis. Glia 52 (2005) 108-118
48. Terayama R., Bando Y., Jiang Y.-P., Mitrovic B., and Yoshida S. Differential expression of protease M/neurosin in oligodendrocytes and their progenitors in an animal model of multiple sclerosis. Neurosci Lett 382 (2005) 82-87
49. Tomizawa K., He X., Yamanaka H., Shiosaka S., and Yoshida S. Injury induces neuropsin mRNA in the central nervous system. Brain Res 824 (1999) 308-311
50. Trapp B.D., Andrews S.B., Cootauco C., and Quarles R. The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes. J Cell Biol 109 (1989) 2417-2426
51. Tsirka S.E., Bugge T.H., Degen J.L., and Strickland S. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci U S A 94 (1997) 9779-9781
52. Warden P., Bamber N.I., Li H., Esposito A., Ahmad K.A., Hsu C.Y., and Xu X.M. Delayed glial cell death following wallerian degeneration in white matter tracts after spinal cord dorsal column cordotomy in adult rats. Exp Neurol 168 (2001) 213-224
53. Wells J.E., Rice T.K., Nuttall R.K., Edwards D.R., Zekki H., Rivest S., and Yong V.W. An adverse role for matrix metalloproteinase 12 after spinal cord injury. J Neurosci 23 (2003) 10107-10115
54. Windebank A.J., Wood P., Bunge R.P., and Dyck P.J. Myelination determines the caliber of dorsal root ganglion neurons in culture. J Neurosci 5 (1985) 1563-1569
55. Wrathall J.R., Choiniere D., and Teng Y.D. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J Neurosci 14 (1994) 6598-6607
56. Wrathall J.R., Teng Y.D., and Marriott R. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma. Exp Neurol 145 (1997) 565-573
57. Yoshida S., and Shiosaka S. Plasticity-related serine proteases in the brain (review). Int J Mol Med 3 (1999) 405-409
58. Yoshida S., Taniguchi M., Hirata A., and Shiosaka S. Sequence analysis and expression of human neuropsin cDNA and gene. Gene 213 (1998) 9-16
59. Yoshida S., Lin L.P., Chen Z.L., Momota Y., Kato K., Tanaka T., Wanaka A., and Shiosaka S. Basal magnocellular and pontine cholinergic neurons coexpress FGF receptor mRNA. Neurosci Res 20 (1994) 35-42
60. Yoshioka A., Bacskai B., and Pleasure D. Pathophysiology of oligodendroglial excitotoxicity. J Neurosci Res 46 (1996) 427-437
61. Yousef G.M., Kishi T., and Diamandis E.P. Role of kallikrein enzymes in the central nervous system. Clin Chim Acta 329 (2003) 1-8
62. Zhang Z., Fujiki M., Guth L., and Steward O. Genetic influences on cellular reactions to spinal cord injury: a wound-healing response present in normal mice is impaired in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration. J Comp Neurol 371 (1996) 485-495